Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 22 OTHER 8 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Platinum-resistant Recurrent Ovarian Cancer 1

Interventions

pembrolizumab 1 niraparib 1 nedaplatin 1 Taxes 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Carboplatin 1 Albumin-Bound Paclitaxel 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × 1-dodecylpyridoxal × Gynecologic × Clear all

NCT04348032 2022-03-31

APPROVE

ChineseAMS

Phase 2 Unknown

Platinum-resistant Recurrent Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡